The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
Abstract Clozapine is considered the golden standard in the treatment of therapy‐resistant schizophrenia; however, it associated with bothersome side effects such as sialorrhea. Current evidence suggests that the sublingual use of atropine seems to be safe and effective and could be considered as a...
Main Authors: | Thomas Van der Poorten, Marc De Hert |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-11-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.2431 |
Similar Items
-
The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea
by: H. Becerra Darriba
Published: (2021-04-01) -
Examining the Role of Sublingual Atropine for the Treatment of Sialorrhea in Patients with Neurodevelopmental Disabilities: A Retrospective Review
by: Kayla Durkin Petkus, et al.
Published: (2023-08-01) -
Dealing With Clozapine-Induced Sialorrhea
by: J. Sá Couto, et al.
Published: (2022-06-01) -
Tropicamide ophthalmic solution reduces clozapine-induced sialorrhea: a case report
by: Ozge Kilic, et al.
Published: (2017-10-01) -
Effects of malathion nebulization on the histopathology of the respiratory tract of Wistar rats, treated with sublingual atropine sulfate eye drops
by: Beatriz de Andrade Monte Alegre, et al.
Published: (2022-04-01)